Zacks Investment Research on MSN
Pfizer (PFE) stock drops despite market gains: Important facts to note
Pfizer (PFE) closed at $27.10 in the latest trading session, marking a -2.62% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.08%. Meanwhile, the Dow ...
Pfizer Inc PFE shares are trading lower on Tuesday after the company and its COVID-19 vaccine partner paused an updated-shot ...
Although it's not generating tons of money from its COVID vaccine and pill anymore, the business is still doing well. There are question marks about its growth prospects, but the company hasn't been ...
TrumpRx/MFN pricing risks could pressure margins despite 9.3x fwd P/E, 6.27% dividend and pipeline gains. Read the latest ...
Good news has been scarce for this beaten-down drugmaker.
A big dividend can’t hide the growth problem at Pfizer (PFE), one of the world’s largest pharmaceutical companies. Pfizer has ...
Pfizer is closing its South San Francisco research site as part of a wider expense reduction effort. Staff at the site are ...
Pfizer Inc. (NYSE:PFE) is included among the 13 Best January Dividend Stocks to Invest in. Pfizer Inc. (NYSE:PFE) is among the drugmakers planning to raise prices on some medicines starting January 1.
Is PFE a good stock to buy now? We came across a bullish thesis on Pfizer Inc. on Investomine’s Substack. In this article, we will summarize the bulls’ thesis on PFE. Pfizer Inc.’s share was trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results